CHASAM: Engagement in Physical Activities and Sports in Adolescents With Diaphragmatic Hernia

Sponsor
University Hospital, Lille (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05666986
Collaborator
APEHDia, a french CDH patient association (Other), Rare Disease Foundation, France (Other)
20
12

Study Details

Study Description

Brief Summary

The objective is to understand how a population of adolescents - who have undergone diaphragm surgery within their first month of life (i.e. subjects who have been carriers of a rare impacting disease such as congenital diaphragmatic hernia (CDH)) - engages in physical and sports activities and what can be the hindering factors as well as the factors facilitating these practices.

Based on self-questionnaires and semi-structured interviews, this research is a qualitative research in the field of human and social sciences.

The qualitative survey will make it possible to report on the experience of the disease of children and parents; in parallel, a complete medical evaluation of the subjects (clinical and para-clinical) will be carried out.

The analysis of the verbatim of the self-questionnaires and interviews with regard to the real physical capacities of the subjects, will be discussed.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Identification of Obstacles and Facilitators to the Engagement in Physical and Sports Activities in a Population of Adolescents Operated on for a Diaphragmatic Hernia
    Anticipated Study Start Date :
    Mar 1, 2023
    Anticipated Primary Completion Date :
    Mar 1, 2024
    Anticipated Study Completion Date :
    Mar 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Adolescents who had CDH surgery in the first month of life,

    without any other pathology, now aged 12-18 and followed up at the CDH Lille Reference Center

    Outcome Measures

    Primary Outcome Measures

    1. Self-questionnaire (for the subjects) [At the time of inclusion]

      to collect the level of investment of the subject in their sport participation (from the subject's point of view)

    2. Self-questionnaire (for the subject's parents) [At the time of inclusion]

      to collect the subject's level of involvement in their sport (from the subject's parents' point of view

    3. semi-directive interview of the subject [At the time of inclusion]

      allowing the identification of the dynamics of involvement in physical activities and sports practices, from the point of view of the subject (the adolescent)

    4. semi-directive interview of the subject's parents [At the time of inclusion]

      allowing the identification of the dynamics of involvement in physical activities and sports practices, from the point of view of the subject's parents

    Secondary Outcome Measures

    1. study of the diaphragmatic kinetics by cardiac MRI [At the time of inclusion]

      Complete clinical examination of the subjects and detailed paraclinical evaluation according to the recommendations of the PNDS with the addition of a sequence during the cardiac MRI allowing the study of the diaphragmatic kinetics.

    2. Self-questionnaire and interviews (for the subjects) [At the time of inclusion]

      Analysis of the verbatim of the self-questionnaires and the interviews, with regard to the real physical capacities of the subjects.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Child/adolescent having undergone surgery for CDH in the first month of life, aged 12 to 18 years; absence of polypathology (i.e. diaphragmatic hernia not associated with another pathology); follow-up at the CDH reference centre, Lille site

    • Written consent from both parents allowing the collection of data from the child/adolescent

    • Written consent from the parent(s) agreeing to participate in the study by answering the questionnaires and the individual interview, for themselves and for their child

    • Possibility of accessing equipment to conduct a video-conference interview if necessary.

    Exclusion Criteria:
    • Parents or child/adolescent not understanding French

    • Parents under guardianship or child under legal protection

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Hospital, Lille
    • APEHDia, a french CDH patient association
    • Rare Disease Foundation, France

    Investigators

    • Principal Investigator: Sébastien MUR, MD, University Hospital, Lille

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Lille
    ClinicalTrials.gov Identifier:
    NCT05666986
    Other Study ID Numbers:
    • 2021_0342
    • 2021-A02518-33
    First Posted:
    Dec 28, 2022
    Last Update Posted:
    Dec 28, 2022
    Last Verified:
    Dec 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Lille
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 28, 2022